Abstract: A holster retainer for releasably retaining a holster having a securing apparatus fixed to the holster for connecting to a mounting apparatus. The holster retainer may include a cavity for securing a holster; a channel configured to receive a securing apparatus of the holster, wherein at least a portion of the channel is disposed within the cavity; and a latch extending along a base of the channel, with the latch configured to releasably engage the securing apparatus of the holster to retain the holster in the holster retainer. A modular holster system may include a holster for supporting a tool, the holster having a securing apparatus; a mounting apparatus configured to receive the securing apparatus of the holster for releasably affixing the holster to a user; and a holster retainer for releasably retaining the holster when the holster is not affixed to the user.

Abstract: Provided are methods for continuous subcutaneous insulin infusion (CSII) that employ a hyaluronan-degrading enzyme, including a recombinant human PH20 (rHuPH20). The methods can be used to more consistently control blood glucose during the course of CSII. The methods can be used to treat subjects having diabetes or other insulin-associated disease or condition.

Abstract: A large-diameter PTFE seal. The lip of the seal is made from a long strip of PTFE bound together at the ends with the aid of a patching tape to form a closed loop.

Abstract: This invention relates to a method for enhancing bone mineral density gain acquired through previous bisphosphonate therapy comprising administering to a human in need thereof a bone-enhancing amount of raloxifene or a pharmaceutically acceptable salt or solvate thereof.